Paclitaxel (T) vs cisplatin VP-16 (EP) in metastatic breast cancer patients treated with anthracyclines: A phase III randomized study, Turkish Oncology Group | AVESİS

Gazi University Research Information System

Paclitaxel (T) vs cisplatin VP-16 (EP) in metastatic breast cancer patients treated with anthracyclines: A phase III randomized study, Turkish Oncology Group

İÇLİ F., AKBULUT H., ÜNER A. , YALÇIN B., ALTINBAŞ M., BALTALI E., ...More

Proceedings of European Society of Clinical Oncology, 18 - 22 October 2002

Publication Type: Conference Paper / Summary Text